计算溶液所需的质量、体积或浓度。
| 活性类型 | 活性值-log(M) | 作用机制 | 期刊 | 参考文献(PubMed IDs) |
|---|
| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| R342110-10μg |
10μg |
现货 ![]() |
| |
| R342110-25μg |
25μg |
现货 ![]() |
|
| 英文别名 | 17-epi-Resolvin D1 | 17(R)-RvD1 | Aspirin-triggered-Resolvin D1 | AT-RvD1 | 7S,8R,17R-trihydroxy-4Z,9E,11E,13Z,15E19Z-docosahexaenoic acid |
|---|---|
| 规格或纯度 | Moligand™, ≥95%, ~0.01% in ethanol |
| 英文名称 | 17(R)-Resolvin D1 |
| 储存温度 | 避光,-80℃储存 |
| 运输条件 | 超低温冰袋运输 |
| 作用类型 | 激动剂 |
| 作用机制 | FPR2/ALX 激动剂;TRPV3 通道阻断剂 |
| 产品介绍 |
17(R)-Resolvin D1在腹膜炎的鼠模型中表现出白细胞浸润的剂量依赖性降低,在100 ng剂量下最大抑制率约为35%。与RESOLVIN D1相反,阿司匹林触发的形式可抵抗类花生酸氧化还原酶的快速失活。 17(R)-Resolvin D1 exhibits a dose-dependent reduction in leukocyte infiltration in a murine model of peritonitis with maximal inhibition of ~35% at a 100 ng dose. In contrast to resolvin D1, the aspirin-triggered form resists rapid inactivation by eicosanoid oxidoreductases. |
| pKa值 | pKₐ: 4.58 (Predicted) |
|---|
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|
| 分子类型 | 小分子 |
|---|---|
| IUPAC Name | (4Z,7S,8R,9E,11E,13Z,15E,17R,19Z)-7,8,17-trihydroxydocosa-4,9,11,13,15,19-hexaenoic acid |
| INCHI | InChI=1S/C22H32O5/c1-2-3-9-14-19(23)15-10-6-4-5-7-11-16-20(24)21(25)17-12-8-13-18-22(26)27/h3-12,15-16,19-21,23-25H,2,13-14,17-18H2,1H3,(H,26,27)/b6-4-,7-5+,9-3-,12-8-,15-10+,16-11+/t19-,20-,21+/m1/s1 |
| InChi Key | OIWTWACQMDFHJG-BJEBZIPWSA-N |
| Canonical SMILES | CCC=CCC(C=CC=CC=CC=CC(C(CC=CCCC(=O)O)O)O)O |
| Isomeric SMILES | CC/C=C\C[C@H](/C=C/C=C\C=C\C=C\[C@H]([C@H](C/C=C\CCC(=O)O)O)O)O |
| PubChem CID | 16126783 |
| UN Number | 1170 |
| Packing Group | II |
| MeSH Entry Terms | 7,8,17-trihydroxy-4,9,11,13,15,19-docosahexaenoic acid;aspirin-triggered resolvin D1;AT-RvD1;resolvin D1;RvD1 fatty acid |
| 分子量 | 376.49 |
| 溶解性 | Soluble in water (~0.05 mg/ml at 25.0 °C), PBS pH 7.2, DMF, and DMSO. |
|---|---|
| 敏感性 | 对光线敏感 |
| 折光率 | n20D1.56 (Predicted) |
| 沸点 | 609.2° C at 760 mmHg |
| 分子量 | 376.500 g/mol |
| XLogP3 | 3.100 |
| 氢键供体数Hydrogen Bond Donor Count | 4 |
| 氢键受体数Hydrogen Bond Acceptor Count | 5 |
| 可旋转键计数Rotatable Bond Count | 14 |
| 精确质量Exact Mass | 376.225 Da |
| 单同位素质量Monoisotopic Mass | 376.225 Da |
| 拓扑极表面积Topological Polar Surface Area | 98.000 Ų |
| 重原子数Heavy Atom Count | 27 |
| 形式电荷Formal Charge | 0 |
| 复杂度Complexity | 555.000 |
| 同位素原子数Isotope Atom Count | 0 |
| 定义的原子立体中心计数Defined Atom Stereocenter Count | 3 |
| 未定义的原子立体中心计数Undefined Atom Stereocenter Count | 0 |
| 定义的键立体中心计数Defined Bond Stereocenter Count | 6 |
| 未定义的键立体中心计数Undefined Bond Stereocenter Count | 0 |
| 所有立体化学键的总数The total count of all stereochemical bonds | 6 |
| 共价键合单元计数Covalently-Bonded Unit Count | 1 |
| Purity(HPLC) | 95-100(%) |
|---|---|
| Proton NMR spectrum | Conforms to structure |
| concentration | 100-130(ppm) |